Zometa

In the US, Zometa (zoledronic acid systemic) is a member of the drug class bisphosphonates and is used to treat Hypercalcemia of Malignancy, Osteolytic Bone Lesions of Multiple Myeloma, Osteolytic Bone Metastases of Solid Tumors, Osteoporosis and Paget's Disease.

US matches:

• Zometa

UK matches:

• Zometa 4mg/5ml Concentrate for Solution for Infusion
• Zometa 4mg/5ml Concentrate for Solution for Infusion (SPC)

Ingredient matches for Zometa

Zoledronic Acid

Zoledronic Acid is reported as an ingredient of Zometa in the following countries:

• Chile


• China


• Denmark


• India


• Indonesia


• Philippines


• Poland


• Singapore


• Sri Lanka


• Taiwan


• Thailand


• Tunisia


• United States

Zoledronic Acid monohydrate (a derivative of Zoledronic Acid) is reported as an ingredient of Zometa in the following countries:

• Australia


• Austria


• Belgium


• Bosnia & Herzegowina


• Brazil


• Canada


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Ecuador


• Finland


• France


• Georgia


• Germany


• Hong Kong


• Hungary


• Iceland


• Ireland


• Italy


• Japan


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Panama


• Portugal


• Romania


• Russian Federation


• Serbia


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Turkey


• United Kingdom


• Venezuela


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.